Seer to Report First Quarter Financial Results on May 10, 2021
April 12 2021 - 4:05PM
Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced it will
report financial results for the first quarter 2021 after market
close on Monday, May 10, 2021. Company management will be
webcasting a conference call beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time.
Live audio of the webcast will be available on
the Investor section of Seer’s website at investor.seer.bio. An
archived replay will be available on the company’s website
following the event.
About SeerSeer is a life sciences company
focused on enabling exceptional scientific outcomes by
commercializing transformative products that will drive
breakthrough ideas by unlocking the deep, unbiased biological
information that can make them a reality. Seer is developing its
Proteograph™ Product Suite, which is an integrated solution
consisting of consumables, automation instrumentation and
proprietary software that performs deep, unbiased proteomics
analysis at scale in a matter of hours. Seer designed the
Proteograph Product Suite to be efficient and easy-to-use,
leveraging widely adopted laboratory instrumentation to provide a
decentralized solution that is broadly available to life sciences
researchers. Seer’s Proteograph Product Suite is for research use
only and is not intended for diagnostic procedures. For more
information, please visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024